Clinical Trial Update: Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 trial comparing dexamethasone versus methylprednisolone for ARDS caused by COVID-19. Status not specified in the source.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Chattogram General Hospital | Conditions: Covid19, ARDS | Phase 3 | Status: UNKNOWN